Rhonda DeMeno

Standardizing Infection Prevention & Control

By

Infection prevention and control (IPC) best practices were already in place against threats such as influenza before the pandemic crisis. During and after the immediate crisis, multiple approaches and practices arose in response to changing knowledge and guidance. Where are we now—and what is needed for today and into the future?

Speakers:

  • Rhonda DeMeno, Director of Clinical Risk, Willis Towers Watson
  • Megan Crosser, Director of Infection Prevention, nodMD

Moderator: John M. Schulte, Vice President, Quality Improvement, Argentum

Understanding and Complying with the New Regulatory Environment

By

As the immediate pandemic threat fades, the prospect and realities of new regulations become top of mind for many operators. This session looks at regulatory trends, priorities and interests for state regulators, and opportunities for industry/regulator collaboration on model guidance. This session also gets into readiness planning, risk assessment/risk management, and other topics to help industry leaders prepare for regulatory changes.

Speakers:

  • Rhonda DeMeno, Director of Clinical Risk, Willis Towers Watson
  • Alfred Johnson, President, National Association for Regulatory Administration (NARA)

Moderator: John M. Schulte, Vice President, Quality Improvement, Argentum